Breaking News, Financial News

Financial Report: Quintiles

Product Development revenues up 8% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles 3Q Revenues: $1.4 billion (+17%) 3Q Earnings: $92.7 million (+39%) YTD Revenues: $4.0 billion (+8%) YTD Earnings: $268.1 million (+75%) Comments: Net new business grew 12.8% to $1.5 billion representing a book-to-bill ratio of 1.42 in the quarter, contributing to an ending backlog of $10.8 billion at September 30. Product Development service revenues grew 8% to $771.4 million in the quarter driven by increases in global lab services, clinical trial support services, functional res...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters